Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/25/1998 | EP0830594A1 Nanofabricated separation matrix for analysis of biopolymers and methods of making and using same |
03/25/1998 | EP0830459A1 Reverse two-hybrid systems |
03/25/1998 | EP0830457A1 Methods for evaluation of antimicrobial targets |
03/25/1998 | EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
03/25/1998 | EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein |
03/25/1998 | EP0830454A1 Gene for enzyme having both alkaline pullulanase and alkaline alpha-amylase activities |
03/25/1998 | EP0830453A2 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity |
03/25/1998 | EP0830452A1 Immune-evading proteins |
03/25/1998 | EP0830451A1 Plant pathogen resistance genes and uses thereof |
03/25/1998 | EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
03/25/1998 | EP0830446A1 In vivo selection of rna-binding peptides |
03/25/1998 | EP0830376A1 Process for producing erythropoietin containing no animal proteins |
03/25/1998 | EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
03/25/1998 | EP0830373A1 Cd6 ligand |
03/25/1998 | EP0830370A1 N-1-carboxyalkyl derivatives of lsd |
03/25/1998 | EP0830367A1 High-affinity nucleic acid ligands of cytokines |
03/25/1998 | EP0830364A1 Method and apparatus for dna extraction |
03/25/1998 | EP0830139A1 Modified myelin protein molecules |
03/25/1998 | EP0830130A1 Tnf-alpha converting enzyme |
03/25/1998 | EP0830062A1 Controlling hemipteran insect pests with bacillus thuringiensis |
03/25/1998 | EP0679094B1 Compounds for targeting |
03/25/1998 | EP0584166B1 Yeast promoter and use thereof |
03/25/1998 | EP0564531B1 Enrichment method for variant proteins with altered binding properties |
03/25/1998 | EP0461165B2 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
03/25/1998 | CN1177380A DNA integration by transposition |
03/25/1998 | CN1177379A Prodn. of gamma linolenic acid by a |
03/25/1998 | CN1177378A Stabilized external guide sequences |
03/25/1998 | CN1177377A Prodn. of enzymatically active recombinant carboxypeptidase B |
03/25/1998 | CN1177376A Novel lipase gene and process for prodn. of lipase with use of same |
03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
03/25/1998 | CN1177342A Novel cationic lipids and the use thereof |
03/25/1998 | CN1177291A Stable lipid-comprising drug delivery complexes and method for producing same |
03/25/1998 | CN1177279A Use of flavonoid aldehydes as insecticides |
03/25/1998 | CN1177008A Synthesis of poly deoxynucleosides, synthesis of chromosome DNA, and method for preparing chromosome |
03/25/1998 | CN1177006A Incasing cell series for prodn. of recombined adenovirus accompanying virus, and the application thereof |
03/25/1998 | CN1177005A Method for gene clone of inhibitory factor for hyperplasia of inner blood vessel cells in human body's real tumor, and using same to anti tumer blood vessel regeneration |
03/25/1998 | CN1177004A Improved riboflavin prodn. |
03/25/1998 | CN1177003A Novel basophilic Bacillus strain and application in degumming of ramie |
03/25/1998 | CN1177002A Method for external gene conversion for spirulina |
03/25/1998 | CN1037844C Tnf-muteins |
03/24/1998 | US5731490 Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1) |
03/24/1998 | US5731489 Transgenic rats containing at least one human gene which participates in blood pressure control |
03/24/1998 | US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
03/24/1998 | US5731427 Nucleic acids encoding a gap-associated protein |
03/24/1998 | US5731426 Phaseolus α-D-galactosidases |
03/24/1998 | US5731425 Synthetic gene |
03/24/1998 | US5731424 High affinity TGFβ nucleic acid ligands and inhibitors |
03/24/1998 | US5731420 Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltransferase |
03/24/1998 | US5731419 Freezing tolerance proteins Wcs19 and Wcor410 from gramineae |
03/24/1998 | US5731415 Lipopolysaccharide binding protein derivatives |
03/24/1998 | US5731412 Protein, DNA coding for same and method of producing the protein |
03/24/1998 | US5731295 Method of reducing stromelysin RNA via ribozymes |
03/24/1998 | US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides |
03/24/1998 | US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
03/24/1998 | US5731280 Recombinant lipase and alpha-amylase variants |
03/24/1998 | US5731202 Methods of regeneration of Medicago sativa and expressing foreign DNA in same |
03/24/1998 | US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein |
03/24/1998 | US5731196 Salmonella virulence genes |
03/24/1998 | US5731195 Specified amino acid sequences |
03/24/1998 | US5731193 Plasmid vector and an interferon promoter increasing produce gene expressed polypeptide |
03/24/1998 | US5731192 Collagen COL4A6: gene, protein and method of detecting collagen deficiency |
03/24/1998 | US5731190 Penton base protein and methods of using same |
03/24/1998 | US5731188 Vaccine |
03/24/1998 | US5731185 Isolated DNA encoding the hphi restriction endonuclease and related methods for producing the same |
03/24/1998 | US5731183 Bacillus-derived transglutaminase |
03/24/1998 | US5731182 Non-mammalian DNA virus to express an exogenous gene in a mammalian cell |
03/24/1998 | US5731181 Chimeric mutational vectors having non-natural nucleotides |
03/24/1998 | US5731180 Imidazolinone resistant AHAS mutants |
03/24/1998 | US5731179 Hydrids |
03/24/1998 | US5731178 Attachment-elements for stimulation of eukaryotic expression systems |
03/24/1998 | US5731176 DNA fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant |
03/24/1998 | US5731174 Process for the saccharification of starch |
03/24/1998 | US5731172 Constructing an adenovirus cosmid wherein a gene has been replaced by an expression unit, digesting adenovirus dna-terminal protein complex, transfecting a cell with the cosmid and producing a recombinant adenovirus |
03/24/1998 | US5731170 DNA encoding a growth factor specific for epithelial cells |
03/24/1998 | US5731169 cDNA fragment coding the alpha interferon receptor gene and process for the preparation of a corresponding protein |
03/24/1998 | US5731168 Method for making heteromultimeric polypeptides |
03/24/1998 | US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them |
03/24/1998 | US5731163 Lyophilized bioluminescent bacterial reagent for the detection of toxicants |
03/24/1998 | US5731154 Method for detecting human contactin |
03/24/1998 | US5731151 Tuberculosis vaccine |
03/24/1998 | US5731150 IS6110 based molecular detection of mycobacterium tuberculosis |
03/24/1998 | US5731149 Antibiotic cryptdin peptides and methods of their use |
03/24/1998 | US5731146 Genetic engineering |
03/24/1998 | US5731144 High affinity TGFβ nucleic acid ligands |
03/24/1998 | US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof |
03/24/1998 | US5730981 Monoclonal anti-ganglioside antibody and its preparation |
03/24/1998 | US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function |
03/24/1998 | US5730970 Pharmaceutical compositions comprising human interleukin-4 (IL-4) |
03/24/1998 | CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy |
03/24/1998 | CA1339777C Superoxide dismutase polymers |
03/24/1998 | CA1339776C Equine-gamma-interferon |
03/24/1998 | CA1339774C Recombinant marek's disease virus, process for preparing the same and vaccine containing the same |
03/24/1998 | CA1339773C Derivative of adult t cell leukemia virus antigen peptide |
03/24/1998 | CA1339772C Method for separating long-chain nucleic acid |
03/23/1998 | CA2196502A1 Compositions and methods for treatment of streptococcus pneumoniae infection |
03/19/1998 | WO1998011508A1 Method and apparatus for analyzing images |
03/19/1998 | WO1998011258A1 Method and apparatus for analysis of chromatographic migration patterns |
03/19/1998 | WO1998011257A1 Methods and compositions for the detection of candida spp. |
03/19/1998 | WO1998011254A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (α), HNF-1β AND HNF-4$g(a) |
03/19/1998 | WO1998011246A2 ENDO-β-GALACTOSIDASE |